581 – 590 of 660
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Progress in haemophilic care: ethical issues.
- Contribution to journal › Article
-
Mark
Unresolved issues in prophylaxis
- Contribution to journal › Article
-
Mark
Antibodies to factor VIIa in patients with haemophilia and high-responding inhibitors.
- Contribution to journal › Article
-
Mark
Multidisciplinär kurs i akutmedicin ger ST-läkare större säkerhet
- Contribution to journal › Article
-
Mark
Roper and rovent scintigraphic points in pulmonary embolism as a safe basis in out-patient tinzaparin therapy
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2001
-
Mark
Anti- and procoagulant activities in factor VII-deficient subjects
- Contribution to journal › Article
-
Mark
The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients
- Contribution to journal › Article
-
Mark
Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis
- Contribution to journal › Article
-
Mark
An approach to study the viral safety of plasma-derived products in previously treated, non-infected patients
- Contribution to journal › Article
-
Mark
Therapeutic choices for patients with hemophilia and high-titer inhibitors
- Contribution to journal › Article